The North America orthopedic devices market size exceeded USD 20.9 billion in 2020 and is expected to witness over 4.1% CAGR from 2021 to 2027. Joint reconstruction devices segment will observe 4.4% growth rate during the forecast timeframe.

North America Orthopedic Devices Market Trends 2021 | Forecast Report 2027 

North America Orthopedic Devices Market Forecast 2027 By Product (Joint Reconstruction Devices {Hip Replacement, Knee Replacement, Ankle Replacement, Shoulder Replacement}, Spinal Devices, Trauma Fixation Devices, Orthobiologics, Arthroscopic Devices), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology 

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Market definition

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; Data sources

1.4.1&nbsp;&nbsp;&nbsp; Secondary

1.4.1.1&nbsp;&nbsp;&nbsp; Paid sources

1.4.1.2&nbsp;&nbsp;&nbsp; Unpaid sources

1.4.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; North America orthopedic devices industry 3600 synopsis, 2016 - 2027

2.1.1&nbsp;&nbsp;&nbsp; Country trends

2.1.2&nbsp;&nbsp;&nbsp; Product trends

Chapter 3&nbsp;&nbsp;&nbsp;North America Orthopedic Devices Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2016 - 2027

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp; Growing base of geriatric population

3.3.1.2&nbsp;&nbsp;&nbsp; Augmented incidence of orthopedic diseases

3.3.1.3&nbsp;&nbsp;&nbsp; Technological advancements

3.3.1.4&nbsp;&nbsp;&nbsp; Escalating rate of orthopedic surgeries

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp; Excessive cost of orthopedic devices

3.3.2.2&nbsp;&nbsp;&nbsp; Stringent FDA regulations and biocompatibility issues

3.3.2.3&nbsp;&nbsp;&nbsp; Post-surgery complications

3.4&nbsp;&nbsp;&nbsp; Analysis of COVID-19 impact on the industry

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; Competitive landscape, 2020

3.7&nbsp;&nbsp;&nbsp; PEST analysis

Chapter 4&nbsp;&nbsp;&nbsp;North America Orthopedic Devices Market, By Product 

4.1&nbsp;&nbsp;&nbsp; Market trends

4.2&nbsp;&nbsp;&nbsp; Joint reconstruction devices

4.2.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.2.2&nbsp;&nbsp;&nbsp; Hip replacement

4.2.2.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.2.3&nbsp;&nbsp;&nbsp; Knee replacement

4.2.3.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.2.4&nbsp;&nbsp;&nbsp; Ankle replacement

4.2.4.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.2.5&nbsp;&nbsp;&nbsp; Shoulder replacement

4.2.5.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.2.6&nbsp;&nbsp;&nbsp; Others

4.2.6.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.3&nbsp;&nbsp;&nbsp; Spinal devices

4.3.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.4&nbsp;&nbsp;&nbsp; Trauma fixation devices

4.4.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.5&nbsp;&nbsp;&nbsp; Orthobiologics

4.5.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.6&nbsp;&nbsp;&nbsp; Arthroscopic devices

4.6.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.7&nbsp;&nbsp;&nbsp; Others

4.7.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 &ndash; 2027 (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;North America Orthopedic Devices Market, By Country

5.1&nbsp;&nbsp;&nbsp; Market trends

5.2&nbsp;&nbsp;&nbsp; U.S.

5.2.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by product, 2016 - 2027 (USD Million)

5.2.1.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by joint reconstruction devices, 2016&ndash; 2027 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Canada

5.3.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by product, 2016 - 2027 (USD Million)

5.3.1.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by joint reconstruction devices, 2016&ndash; 2027 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Company Profiles

6.1&nbsp;&nbsp;&nbsp; aap Implantate AG

6.1.1&nbsp;&nbsp;&nbsp; Business overview

6.1.2&nbsp;&nbsp;&nbsp; Financial data

6.1.3&nbsp;&nbsp;&nbsp; Product landscape

6.1.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.1.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.2&nbsp;&nbsp;&nbsp; Alphatec Spine Inc.

6.2.1&nbsp;&nbsp;&nbsp; Business overview

6.2.2&nbsp;&nbsp;&nbsp; Financial data

6.2.3&nbsp;&nbsp;&nbsp; Product landscape

6.2.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.2.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.3&nbsp;&nbsp;&nbsp; Arthrex

6.3.1&nbsp;&nbsp;&nbsp; Business overview

6.3.2&nbsp;&nbsp;&nbsp; Financial data

6.3.3&nbsp;&nbsp;&nbsp; Product landscape

6.3.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.3.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.4&nbsp;&nbsp;&nbsp; B. Braun Melsungen AG

6.4.1&nbsp;&nbsp;&nbsp; Business overview

6.4.2&nbsp;&nbsp;&nbsp; Financial data

6.4.3&nbsp;&nbsp;&nbsp; Product landscape

6.4.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.4.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.5&nbsp;&nbsp;&nbsp; ConforMIS, Inc.

6.5.1&nbsp;&nbsp;&nbsp; Business overview

6.5.2&nbsp;&nbsp;&nbsp; Financial data

6.5.3&nbsp;&nbsp;&nbsp; Product landscape

6.5.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.5.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.6&nbsp;&nbsp;&nbsp; CONMED Corporation

6.6.1&nbsp;&nbsp;&nbsp; Business overview

6.6.2&nbsp;&nbsp;&nbsp; Financial data

6.6.3&nbsp;&nbsp;&nbsp; Product landscape

6.6.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.6.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.7&nbsp;&nbsp;&nbsp; DePuy Synthes (Johnson and Johnson)

6.7.1&nbsp;&nbsp;&nbsp; Business overview

6.7.2&nbsp;&nbsp;&nbsp; Financial data

6.7.3&nbsp;&nbsp;&nbsp; Product landscape

6.7.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.7.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.8&nbsp;&nbsp;&nbsp; DJO Global

6.8.1&nbsp;&nbsp;&nbsp; Business overview

6.8.2&nbsp;&nbsp;&nbsp; Financial data

6.8.3&nbsp;&nbsp;&nbsp; Product landscape

6.8.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.8.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.9&nbsp;&nbsp;&nbsp; Globus Medical

6.9.1&nbsp;&nbsp;&nbsp; Business overview

6.9.2&nbsp;&nbsp;&nbsp; Financial data

6.9.3&nbsp;&nbsp;&nbsp; Product landscape

6.9.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.9.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.10&nbsp;&nbsp;&nbsp; Integra LifeSciences

6.10.1&nbsp;&nbsp;&nbsp; Business overview

6.10.2&nbsp;&nbsp;&nbsp; Financial data

6.10.3&nbsp;&nbsp;&nbsp; Product landscape

6.10.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.10.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.11&nbsp;&nbsp;&nbsp; Medacta

6.11.1&nbsp;&nbsp;&nbsp; Business overview

6.11.2&nbsp;&nbsp;&nbsp; Financial data

6.11.3&nbsp;&nbsp;&nbsp; Product landscape

6.11.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.11.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.12&nbsp;&nbsp;&nbsp; Medtronic

6.12.1&nbsp;&nbsp;&nbsp; Business overview

6.12.2&nbsp;&nbsp;&nbsp; Financial data

6.12.3&nbsp;&nbsp;&nbsp; Product landscape

6.12.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.12.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.13&nbsp;&nbsp;&nbsp; Microport Scientific Corporation

6.13.1&nbsp;&nbsp;&nbsp; Business overview

6.13.2&nbsp;&nbsp;&nbsp; Financial data

6.13.3&nbsp;&nbsp;&nbsp; Product landscape

6.13.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.13.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.14&nbsp;&nbsp;&nbsp; NuVasive

6.14.1&nbsp;&nbsp;&nbsp; Business overview

6.14.2&nbsp;&nbsp;&nbsp; Financial data

6.14.3&nbsp;&nbsp;&nbsp; Product landscape

6.14.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.14.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.15&nbsp;&nbsp;&nbsp; Smith &amp; Nephew

6.15.1&nbsp;&nbsp;&nbsp; Business overview

6.15.2&nbsp;&nbsp;&nbsp; Financial data

6.15.3&nbsp;&nbsp;&nbsp; Product landscape

6.15.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.15.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.16&nbsp;&nbsp;&nbsp; Stryker

6.16.1&nbsp;&nbsp;&nbsp; Business overview

6.16.2&nbsp;&nbsp;&nbsp; Financial data

6.16.3&nbsp;&nbsp;&nbsp; Product landscape

6.16.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.16.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.17&nbsp;&nbsp;&nbsp; TriMed Inc.

6.17.1&nbsp;&nbsp;&nbsp; Business overview

6.17.2&nbsp;&nbsp;&nbsp; Financial data

6.17.3&nbsp;&nbsp;&nbsp; Product landscape

6.17.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.17.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.18&nbsp;&nbsp;&nbsp; Waldemar LINK

6.18.1&nbsp;&nbsp;&nbsp; Business overview

6.18.2&nbsp;&nbsp;&nbsp; Financial data

6.18.3&nbsp;&nbsp;&nbsp; Product landscape

6.18.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.18.5&nbsp;&nbsp;&nbsp; SWOT analysis

6.19&nbsp;&nbsp;&nbsp; Zimmer Biomet

6.19.1&nbsp;&nbsp;&nbsp; Business overview

6.19.2&nbsp;&nbsp;&nbsp; Financial data

6.19.3&nbsp;&nbsp;&nbsp; Product landscape

6.19.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.19.5&nbsp;&nbsp;&nbsp; SWOT analysis 
&nbsp;